# Ebrahim S. Delpassand

> Ebrahim S. Delpassand is the Houston-based founder, chairman and CEO of RadioMedix, which he established in January 2006. His company-building record includes personally financing early research, developing the SPICA manufacturing operation and forming international licensing and supply partnerships. RadioMedix marked its twentieth anniversary in 2026.

- **Role:** Founder, Chairman and CEO at RadioMedix, Inc.
- **Organizations:** RadioMedix, Inc., Baylor College of Medicine, MD Anderson Cancer Center, University of Texas Medical Branch
- **Education:** Postgraduate residency training (not a degree), Baylor College of Medicine
- **Known for:** Founded RadioMedix in January 2006 and continues to serve as chairman and CEO., Built a business combining research, manufacturing services and international partnerships., RadioMedix and Orano Med secured a 2024 Sanofi licensing agreement with €100 million upfront jointly, up to €220 million in sales milestones and tiered royalties.

## Career timeline

- **1991** — Completed postgraduate residency training at Baylor College of Medicine.
- **2006** — Founded RadioMedix in January in Houston.
- **2006-2011** — Personally financed RadioMedix research, as he recounted in a 2026 interview.
- **2024** — RadioMedix and Orano Med entered a licensing agreement with Sanofi on September 12.
- **2025** — RadioMedix signed a five-year supply framework agreement with Thor Medical on December 4, with supply scheduled to begin in 2026.
- **2026** — RadioMedix marked its twentieth anniversary and appointed Brian A. Markison as its second independent director, effective July 1.

## Achievements

- Founded RadioMedix in January 2006 and continues to serve as chairman and CEO.
- Built a business combining research, manufacturing services and international partnerships.
- RadioMedix and Orano Med secured a 2024 Sanofi licensing agreement with €100 million upfront jointly, up to €220 million in sales milestones and tiered royalties.

## Latest updates

- **2026-07** — RadioMedix announced Brian A. Markison’s appointment as its second independent director, effective July 1; the company announcement was dated July 15.
- **2026-07** — Appeared on Ira Pastor’s Progress, Potential, and Possibilities podcast on July 7.
- **2026-05** — RadioMedix marked twenty years in business and announced Delpassand’s participation in the annual SNMMI meeting in Los Angeles.

## Links

- Website: https://radiomedix.com/
- LinkedIn: https://www.linkedin.com/in/ebrahim-delpassand-m-d-60318234

---

Profile page: https://yespress.io/ebrahim-delpassand
Published by YesPress — https://yespress.io
Last updated: 2026-10-25